PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+28.08%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.67B
AUM Growth
+$1.67B
(-20%)
Cap. Flow
-$852M
Cap. Flow
% of AUM
-51.1%
Top 10 Holdings %
Top 10 Hldgs %
45.69%
Holding
79
New
7
Increased
15
Reduced
27
Closed
15
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$60.6M |
| 2 |
Universal Health Services
UHS
|
$17M |
| 3 |
Avantor
AVTR
|
$15.4M |
| 4 |
Stryker
SYK
|
$13.9M |
| 5 |
Boston Scientific
BSX
|
$13.8M |
Top Sells
| 1 |
Praxis Precision Medicines
PRAX
|
$184M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$59.7M |
| 3 |
Cardinal Health
CAH
|
$55.5M |
| 4 |
Cytokinetics
CYTK
|
$53.6M |
| 5 |
UnitedHealth
UNH
|
$50.9M |
Sector Composition
| 1 | Healthcare | 96.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $174M | 10.44% | 298,643 | – | – |
|
|
2
Cytokinetics
CYTK
$4.23B
| $147M | 8.8% | 1,757,192 -642,353 | -27% | -$53.6M |
|
3
Merck
MRK
$210B
| $65M | 3.9% | 596,261 | – | – |
|
4
AbbVie
ABBV
$372B
| $63.1M | 3.78% | 407,013 -94,179 | -19% | -$14.6M |
|
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $60.6M | 3.63% | +148,852 | New | +$60.6M |
|
6
Humana
HUM
$36.5B
| $57.4M | 3.44% | 125,340 -40,726 | -25% | -$18.6M |
|
7
Edwards Lifesciences
EW
$47.8B
| $56.4M | 3.39% | 740,260 +37,672 | +5% | +$2.87M |
|
8
Becton Dickinson
BDX
$55.3B
| $48.8M | 2.93% | 200,041 +46,086 | +30% | +$11.2M |
|
9
McKesson
MCK
$85.4B
| $45.1M | 2.71% | 97,498 | – | – |
|
10
Tenet Healthcare
THC
$16.3B
| $44.5M | 2.67% | 589,409 +10,705 | +2% | +$809K |
|
11
Centene
CNC
$14.3B
| $41.4M | 2.48% | 557,751 -232,117 | -29% | -$17.2M |
|
|
KRTX
12
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $41.2M | 2.47% | 130,293 -7,916 | -6% | -$2.51M |
|
13
Legend Biotech
LEGN
$6.41B
| $40.9M | 2.45% | 679,076 | – | – |
|
14
Penumbra
PEN
$10.6B
| $39.2M | 2.35% | 155,786 -36,620 | -19% | -$9.21M |
|
15
Axsome Therapeutics
AXSM
$6.05B
| $37.2M | 2.23% | 467,427 -55,783 | -11% | -$4.44M |
|
16
Caribou Biosciences
CRBU
$174M
| $37.1M | 2.23% | 6,480,764 -243,951 | -4% | -$1.4M |
|
17
HCA Healthcare
HCA
$94.5B
| $33.8M | 2.03% | 124,840 +5,305 | +4% | +$1.44M |
|
18
argenx
ARGX
$43.6B
| $33M | 1.98% | 86,832 -17,900 | -17% | -$6.81M |
|
|
19
Universal Health Services
UHS
$11.6B
| $30.8M | 1.85% | 202,292 +111,783 | +124% | +$17M |
|
20
Danaher
DHR
$147B
| $29M | 1.74% | 125,515 -50,175 | -29% | -$11.6M |
|
21
Icon
ICLR
$13.8B
| $28.8M | 1.73% | 101,812 -111,747 | -52% | -$31.6M |
|
22
Thermo Fisher Scientific
TMO
$186B
| $27.2M | 1.63% | 51,328 -10,815 | -17% | -$5.74M |
|
23
IQVIA
IQV
$32.4B
| $25.9M | 1.55% | 111,854 -89,183 | -44% | -$20.6M |
|
24
Molina Healthcare
MOH
$9.8B
| $25.3M | 1.52% | 70,088 -73,691 | -51% | -$26.6M |
|
25
Acadia Healthcare
ACHC
$2.12B
| $23.9M | 1.44% | 307,937 -69,932 | -19% | -$5.44M |
|